Provided by Tiger Trade Technology Pte. Ltd.

Acadia

20.45
-0.0200-0.10%
Post-market: 20.450.00000.00%17:42 EDT
Volume:2.47M
Turnover:50.46M
Market Cap:2.81B
PE:60.52
High:20.58
Open:20.53
Low:20.26
Close:20.47
52wk High:23.03
52wk Low:18.61
Shares:137.33M
Float Shares:136.63M
Volume Ratio:2.19
T/O Rate:1.81%
Dividend:0.80
Dividend Rate:3.91%
EPS(TTM):0.3379
EPS(LYR):0.0950
ROE:5.71%
ROA:1.18%
PB:1.20
PE(LYR):215.20

Loading ...

Acadia Pharmaceuticals is Maintained at Buy by Citigroup

Dow Jones
·
Aug 25

Acadia Pharmaceuticals price target raised to $28 from $27 at Morgan Stanley

TIPRANKS
·
Aug 25

Acadia Pharmaceuticals price target raised to $40 from $39 at Citi

TIPRANKS
·
Aug 25

Analysts’ Top Real Estate Picks: Macerich (MAC), Acadia Realty (AKR)

TIPRANKS
·
Aug 24

Acadia Pharmaceuticals Gets European Approval of Rett Syndrome Drug Daybu

Dow Jones
·
Aug 24

Acadia Realty Trust Shares Rise After KeyBanc Upgrade

MT Newswires Live
·
Aug 19

Acadia Realty Trust Price Target Announced at $25.00/Share by Keybanc

Dow Jones
·
Aug 18

Acadia Realty Trust upgraded to Overweight from Sector Weight at KeyBanc

TIPRANKS
·
Aug 18

Acadia Pharmaceuticals is Maintained at Buy by UBS

Dow Jones
·
Aug 17

Acadia Realty Trust Earnings Call Signals Street Retail Strength

TIPRANKS
·
Aug 15

Acadia Pharmaceuticals to Gain From Daybue, Nuplazid Growth; RADIANT Data Adds Risk, Morgan Stanley Says

MT Newswires Live
·
Aug 10

Acadia Realty Trust Declares USD 0.20 Quarterly Dividend Per Share

Reuters
·
Aug 06

Acadia Pharmaceuticals is Maintained at Perform by Oppenheimer

Dow Jones
·
Aug 06

Acadia Pharmaceuticals: Buy Rating Reiterated as Growth Drivers Strengthen; Price Target Maintained at $36

TIPRANKS
·
Aug 05

Acadia Pharmaceuticals price target raised to $25 from $23 at Oppenheimer

TIPRANKS
·
Aug 05

Acadia Pharmaceuticals price target raised to $36 from $35 at Citizens

TIPRANKS
·
Aug 05

Neuren Pharmaceuticals Partner Acadia Reports Record Q2 Daybue Sales; Shares Up 17%

MT Newswires Live
·
Aug 05

Acadia Pharmaceuticals reports Q2 EPS 18c, consensus 4c

TIPRANKS
·
Aug 05

Acadia raises FY26 revenue view to $1.24B-$1.3B from $1.22B-$1.28B

TIPRANKS
·
Aug 05

Acadia Realty Trust is Maintained at Buy by Citigroup

Dow Jones
·
Aug 04